Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp; Christine Cornforth; Richard Jackson; Jane Harrold; Mark A. Turner; Louise Kenny; Philip N. Baker; Edward D. Johnstone; Asma Khalil; Peter von Dadelszen; Aris T. Papageorghiou; Zarko Alfirevic

doi:10.1016/S2352-4642(19)30020-3

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Andrew Sharp
, Christine Cornforth
, Richard Jackson
, Jane Harrold
, Mark A. Turner
, Louise Kenny
, Philip N. Baker
, Edward D. Johnstone
, Asma Khalil
, Peter von Dadelszen
, Aris T. Papageorghiou
, Zarko Alfirevic

Research output: Contribution to journal › Comment/debate › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	e2-e3
Number of pages	2
Journal	The Lancet Child and Adolescent Health
Volume	3
Issue number	3
DOIs	https://doi.org/10.1016/S2352-4642(19)30020-3
Publication status	Published - Mar 2019

Access to Document

10.1016/S2352-4642(19)30020-3

Cite this

Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., Baker, P. N., Johnstone, E. D., Khalil, A., von Dadelszen, P., Papageorghiou, A. T., & Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. The Lancet Child and Adolescent Health, 3(3), e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

@article{82533803c9ef47da9fed72e706bcfe5b,

title = "Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction",

author = "Andrew Sharp and Christine Cornforth and Richard Jackson and Jane Harrold and Turner, \{Mark A.\} and Louise Kenny and Baker, \{Philip N.\} and Johnstone, \{Edward D.\} and Asma Khalil and \{von Dadelszen\}, Peter and Papageorghiou, \{Aris T.\} and Zarko Alfirevic",

year = "2019",

month = mar,

doi = "10.1016/S2352-4642(19)30020-3",

language = "English",

volume = "3",

pages = "e2--e3",

journal = "The Lancet Child and Adolescent Health",

issn = "2352-4642",

publisher = "Elsevier",

number = "3",

}

Sharp, A, Cornforth, C, Jackson, R, Harrold, J, Turner, MA, Kenny, L, Baker, PN, Johnstone, ED, Khalil, A, von Dadelszen, P, Papageorghiou, AT & Alfirevic, Z 2019, 'Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction', The Lancet Child and Adolescent Health, vol. 3, no. 3, pp. e2-e3. https://doi.org/10.1016/S2352-4642(19)30020-3

TY - JOUR

T1 - Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

AU - Sharp, Andrew

AU - Cornforth, Christine

AU - Jackson, Richard

AU - Harrold, Jane

AU - Turner, Mark A.

AU - Kenny, Louise

AU - Baker, Philip N.

AU - Johnstone, Edward D.

AU - Khalil, Asma

AU - von Dadelszen, Peter

AU - Papageorghiou, Aris T.

AU - Alfirevic, Zarko

PY - 2019/3

Y1 - 2019/3

UR - https://www.scopus.com/pages/publications/85061374987

U2 - 10.1016/S2352-4642(19)30020-3

DO - 10.1016/S2352-4642(19)30020-3

M3 - Comment/debate

C2 - 30704877

AN - SCOPUS:85061374987

SN - 2352-4642

VL - 3

SP - e2-e3

JO - The Lancet Child and Adolescent Health

JF - The Lancet Child and Adolescent Health

IS - 3

ER -

Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction

Access to Document

Other files and links

Cite this